We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Wants More Efforts to Guard Against Viruses in Biologics
FDA Wants More Efforts to Guard Against Viruses in Biologics
January 6, 2011
The FDA is expecting biologics manufacturers to work harder to reduce the possibility of adventitious virus contamination at contract manufacturers, as well as their own sites, after recent significant and preventable contaminations, an FDA official says.